Archive - January 2019
Understanding Absolute Stoichiometry of Oligomeric Protein Complexes using SEC-MALS
FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
Imbruvica and Gazyvo approved in first non-chemo CLL use
Lords continue to call for clarity on ‘no-deal Brexit’ medicines access
Hardy returns to Genentech as CEO
Morphosys’ Darzalex patent challenge hits a hurdle
Novartis urges government to ‘minimise disruption’ in no-deal Brexit
Destiny Pharma to get £1.6M grant for AMR